Lindsey Allen | executive |
Justin Klee | executive |
James Frates | executive |
Camille Bedrosian | executive |
Joshua Cohen | executive |
Chen Yang | analyst |
Neena Bitritto-Garg | analyst |
Corinne Jenkins | analyst |
Michael DiFiore | analyst |
Graig Suvannavejh | analyst |
Madhumita Yennawar | analyst |
Ananda Ghosh | analyst |
Good morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request.I would now like to turn the call over to Lindsey Allen, Head, Investor Relations and Communications. Please proceed.